The Form 4 filing, a report of insider stock activity, was filed on Nov. 12, 2026. The sale took place on Nov. 9, three days earlier. It lists Jamil Farshchi as Equifax's executive vice president and chief technology officer.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 15,110 |
| Price | $189.77 |
| Total Transaction Value | $2,867,424.70 |
| Insider | |
| Ticker Symbol | EFX |
| Company | EQUIFAX INC |
| Insider Name | Farshchi Jamil |
| Insider Title | EVP, Chief Technology Officer |
| Sector - Industry | Industrials - Consulting Services |
| Holdings | |
| Total Shares Owned After Transaction | 39,290 |
| Position Size Change | 27.78% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Equifax (EFX) shares, reported with transaction code S. The record lists one sale on Nov. 9, 2026.
What was the average price of the transaction?
The average price was $189.77 per share.
How did this transaction affect the insider's holdings?
Jamil Farshchi sold 15,110 shares and reported owning 39,290 shares afterward. The sale was 27.78% of the shares he held before the trade.
What's the total transaction value?
The total value was $2,867,424.70 for the one reported sale.
Are there any special circumstances around this transaction?
The transaction information includes references to a Rule 10b5-1 trading plan and dividend reinvestment. A Rule 10b5-1 plan sets trading instructions in advance. Whether the plan reference covers this sale or the filing as a whole is unknown. Its adoption date and trading schedule are also unknown.
Dividend reinvestment uses dividends, or payments to shareholders, to buy more shares. The reference could relate to shares already counted in the total owned afterward. Its link to this sale is unclear. The filing's footnote text was unavailable for this report, so the details of both arrangements remain unknown.
For research purposes only; not investment advice.